echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA Sub-Journal: On the basis of aspirin, ticagrelor vs. clopidogrel DAPT has no difference in the effect of treating stroke!

    JAMA Sub-Journal: On the basis of aspirin, ticagrelor vs. clopidogrel DAPT has no difference in the effect of treating stroke!

    • Last Update: 2021-12-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Dual antiplatelet therapy (DAPT) of clopidogrel and aspirin can effectively prevent minor ischemic stroke or recurrent stroke after transient ischemic attack (TIA)
    .


    Recently, some experts have suggested that evidence of ticagrelor combined with aspirin therapy is emerging, and the two DAPT regimens have not been directly compared


    Dual antiplatelet therapy (DAPT) of clopidogrel and aspirin can effectively prevent minor ischemic stroke or recurrent stroke after transient ischemic attack (TIA)


    JAMA

    Search data from MEDLINE, Embase, and Cochrane from the beginning to February 2021
    .


    The study selected randomized clinical trials that recruited adults with acute minor ischemic stroke or TIA, and provided the above interventions within 72 hours after the onset of symptoms, and followed up for at least 30 days


    The main result is the combined result of recurrent stroke or death within 90 days
    .


    Secondary outcomes include major bleeding, mortality, adverse events, and dysfunction


    Results A total of 4,014 citations were screened; 5 randomized clinical trials were included
    .


    Data of 22,098 patients were analyzed, including 5517 in the clopidogrel and aspirin group, 5,859 in the ticagrelor and aspirin group, and 10,722 in the aspirin group


    Compared with aspirin alone, clopidogrel and aspirin (HR=0.
    74; 95% CrI, 0.
    65-0.
    84) and ticagrelor and aspirin (HR=0.
    79; 95% CrI, 0.
    68-0.
    91) are effective in preventing recurrent stroke and The death rate was better, reducing 26% and 21% respectively
    .


    Compared with clopidogrel and aspirin and aspirin ticagrelor no statistically significant differences in school (the HR = 0.


    Compared with aspirin alone, clopidogrel and aspirin (HR=0.


    Differences in the main treatment outcomes of the three treatment groups

    At the same time, the major bleeding rates of the two DAPT regimens are higher than that of aspirin alone
    .


    Compared with aspirin alone (HR=0.


    Compared with aspirin alone (HR=0.


    In summary, DAPT combined with aspirin and ticagrelor or clopidogrel is better than aspirin alone, but in terms of the main results, no statistically significant difference was found between the two regimens


    references:

    references:

    Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
    JAMA Neurol.
    Published online December 06, 2021.
    doi:10.
    1001/jamaneurol.
    2021.
    4514

    Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.